Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
TELA Bio, Inc. (TELA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
8-K
| Investor presentation, Quarterly results |
| 05/11/2023 |
8-K
| Investor presentation, Quarterly results |
| 03/21/2023 |
8-K
| Investor presentation, Quarterly results |
| 11/09/2022 |
8-K
| Quarterly results |
| 08/10/2022 |
8-K
| Quarterly results |
| 05/10/2022 |
8-K
| Quarterly results |
| 03/21/2022 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"TELA Bio, Inc. Consolidated Balance Sheets December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 43,931 $ 74,394 Accounts receivable, net 4,234 2,683 Inventory 7,658 3,907 Prepaid expenses and other assets 3,232 2,241 Total current assets 59,055 83,225 Property and equipment, net 1,186 626 Intangible assets, net 2,303 2,607 Total assets $ 62,544 $ 86,458 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 2,414 $ 652 Accrued expenses and other current liabilities 8,161 5,953 Total current liabilities 10,575 6,605 Long-term debt with related party 31,491 30,827 Other long-term liabilities 380 — Total liabilities 42,446 37,432 Stockholders’ equity: Preferred stock; $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding —...",
"Advancing Soft Tissue Reconstruction Investor Presentation March 2022" |
|
| 11/10/2021 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"TELA Bio, Inc. Consolidated Balance Sheets September 30, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 53,636 $ 74,394 Accounts receivable, net 3,573 2,683 Inventory 6,269 3,907 Prepaid expenses and other assets 2,061 2,241 Total current assets 65,539 83,225 Property and equipment, net 891 626 Intangible assets, net 2,379 2,607 Total assets $ 68,809 $ 86,458 Liabilities and stockholders' equity Current liabilities: Accounts payable $ 2,334 $ 652 Accrued expenses and other current liabilities 7,043 5,953 Total current liabilities 9,377 6,605 Long-term debt with related party 31,315 30,827 Other long-term liabilities 388 — Total liabilities 41,080 37,432 Stockholders’ equity: Preferred stock; $0.001 par value: 10,000,000 shares authorized; no shares issued and ou...",
"Corporate Slide Deck" |
|
| 03/24/2021 |
8-K
| Quarterly results |
| 11/12/2020 |
8-K
| Quarterly results|
Docs:
|
"TELA Bio, Inc. Consolidated Balance Sheets September 30, December 31, 2020 2019 Assets Current assets: Cash and cash equivalents $ 81,467 $ 45,302 Short-term investments — 9,285 Accounts receivable, net 2,640 2,836 Inventory 4,042 4,603 Prepaid expenses and other assets 867 2,308 Total current assets 89,016 64,334 Property and equipment, net 652 677 Intangible assets, net 2,683 2,911 Total assets $ 92,351 $ 67,922 Liabilities and stockholders’ equity Current liabilities: Accounts payable $ 976 $ 3,171 Accrued expenses and other current liabilities 4,369 3,542 Total current liabilities 5,345 6,713 Long-term debt with related party 30,673 30,243 Other long-term liabilities — 4 Total liabilities 36,018 36,960 Stockholders’ equity: Preferred stock; $0.001 par value: 10,000,000 shares authoriz..." |
|
| 08/12/2020 |
8-K
| Quarterly results |
| 05/12/2020 |
8-K
| Quarterly results |
| 03/27/2020 |
8-K
| Quarterly results|
Docs:
|
"TELA Bio, Inc. Consolidated Balance Sheets December 31, 2019 2018 Assets Current assets: Cash and cash equivalents $ 45,302 $ 17,278 Short-term investments 9,285 — Accounts receivable, net 2,836 1,298 Inventory 4,603 4,348 Prepaid expenses and other assets 2,308 330 Total current assets 64,334 23,254 Property and equipment, net 677 758 Intangible assets, net 2,911 3,215 Total assets $ 67,922 $ 27,227 Liabilities, redeemable convertible preferred stock and stockholders’ equity Current liabilities: Accounts payable $ 3,171 $ 3,421 Accrued expenses 3,533 5,153 Other current liabilities 9 985 Total current liabilities 6,713 9,559 Long-term debt with related party 30,243 29,733 Preferred stock warrant liability — 1,640 Other long-term liabilities 4 5 Total liabilities 36,960 40,937 Redeemable c..." |
|
| 12/18/2019 |
8-K
| Quarterly results|
Docs:
|
"TELA BIO, INC. Consolidated Balance Sheets September 30, December 31, 2019 2018 Assets Current assets: Cash and cash equivalents $ 10,701 $ 17,278 Accounts receivable 2,278 1,298 Inventory 4,272 4,348 Prepaid expenses and other 365 330 Total current assets 17,616 23,254 Property and equipment, net 716 758 Intangible assets, net 2,987 3,215 Deferred offering costs 1,731 — Total assets $ 23,050 $ 27,227 Liabilities, redeemable convertible preferred stock, and stockholders’ deficit Current liabilities: Accounts payable $ 1,701 $ 3,421 Accrued expenses 3,600 5,153 Other current liabilities 1,008 985 Total current liabilities 6,309 9,559 Long-term debt with related party 30,108 29,733 Preferred stock warrant liability 1,644 1,640 Other long-term liabilities 5 5 Total liabilities 38,066 40,937 ..." |
|
|
|